These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15514689)

  • 1. Retrospective Study of Olanzapine in Depressive and Anxious States in Primary Care.
    Jackson WC; Manning JS; Connor PD; Deardorff OG
    Prim Care Companion J Clin Psychiatry; 2004; 6(5):199-202. PubMed ID: 15514689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.
    Narendran R; Young CM; Valenti AM; Pristach CA; Pato MT; Grace JJ
    J Clin Psychiatry; 2001 Jul; 62(7):509-16. PubMed ID: 11488360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study.
    Maina G; Albert U; Rosso G; Bogetto F
    J Clin Psychiatry; 2008 Apr; 69(4):609-16. PubMed ID: 18294024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
    Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
    Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.
    Miller DS; Yatham LN; Lam RW
    J Clin Psychiatry; 2001 Dec; 62(12):975-80. PubMed ID: 11780879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
    J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
    Trivedi MH; Thase ME; Osuntokun O; Henley DB; Case M; Watson SB; Campbell GM; Corya SA
    J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
    Maher AR; Theodore G
    J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder.
    Zajecka JM; Weisler R; Sachs G; Swann AC; Wozniak P; Sommerville KW
    J Clin Psychiatry; 2002 Dec; 63(12):1148-55. PubMed ID: 12523875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
    Tohen M; Chengappa KN; Suppes T; Zarate CA; Calabrese JR; Bowden CL; Sachs GS; Kupfer DJ; Baker RW; Risser RC; Keeter EL; Feldman PD; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bipolar II disorder : epidemiology, diagnosis and management.
    Benazzi F
    CNS Drugs; 2007; 21(9):727-40. PubMed ID: 17696573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Risperidone and Olanzapine in Bipolar and Schizoaffective Disorders.
    Masand PS; Wang X; Gupta S; Schwartz TL; Virk S; Hameed A
    Prim Care Companion J Clin Psychiatry; 2002 Apr; 4(2):70-73. PubMed ID: 15014747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of bipolar mixed state with olanzapine.
    Sharma V; Pistor L
    J Psychiatry Neurosci; 1999 Jan; 24(1):40-4. PubMed ID: 9987206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder.
    Barbee JG; Conrad EJ; Jamhour NJ
    J Clin Psychiatry; 2004 Jul; 65(7):975-81. PubMed ID: 15291687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder.
    Vieta E; Sánchez-Moreno J; Goikolea JM; Colom F; Martínez-Arán A; Benabarre A; Corbella B; Torrent C; Comes M; Reinares M; Brugue E
    J Clin Psychopharmacol; 2004 Aug; 24(4):374-8. PubMed ID: 15232327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.